pyrroles has been researched along with mycophenolic acid in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.57) | 18.2507 |
| 2000's | 5 (17.86) | 29.6817 |
| 2010's | 22 (78.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bechtel, L; D'Aquila, RT; Hirsch, MS; Hsiung, GD; Kaplan, JC; Margalith, M; Medina, DJ; Skolnik, PR; Smith, BR; Wang, MZ | 1 |
| Chang, G; DeNofrio, D; Goldberg, L; Kao, A; Kolansky, DM; Loh, E; Pickering, F; Sasseen, B; See, VY; Wilensky, RL | 1 |
| Ball, DJ; Borie, DC; Brissette, WH; Campbell, A; Changelian, PS; Elliott, EA; Flores, MG; Higgins, JP; Kudlacz, EM; Larson, MJ; Reitz, BA; Rousvoal, G; Zhang, S | 1 |
| Brennan, D; Chan, G; Chow, V; Gaston, R; Krishnaswami, S; Mendez, R; Ni, G; Pescovitz, MD; Pirsch, J; Swan, S; van Gurp, E; Wang, C; Weimar, W | 1 |
| Brennan, DC; Bromberg, JS; Busque, S; Chan, G; Fisher, RA; Hariharan, S; Klintmalm, G; Lawendy, N; Leventhal, J; Mulgaonkar, S; Peddi, VR; Shah, T; Slakey, D; Steinberg, S; Vincenti, F; Wang, C | 1 |
| Baan, CC; Chan, G; Korevaar, SS; Mol, W; Quaedackers, ME; van Gurp, EA; van Ijcken, WF; Weimar, W | 1 |
| Busque, S; Chan, G; Krishnaswami, S; Lamba, M; Melcher, M; Tafti, B | 1 |
| Brunet, M; Cofán, F; Cofán, M; Guillén, D; Millán, O; Ros, E | 1 |
| Budde, K; Glander, P; Mashreghi, MF; Matz, M; Naik, M; Neumayer, HH | 1 |
| Arns, W; Budde, K; Dantal, J; Grinyo, JM; Kovarik, JM; Proot, P; Rostaing, L; Steiger, JU | 1 |
| Abrams, K; Arns, W; Banas, B; Budde, K; Chan, L; Cibrik, D; Friman, S; Klempnauer, J; Mulgaonkar, S; Nashan, B; Nicholson, M; Vincenti, F; Wahlberg, J; Wissing, KM; Witte, S; Woodle, ES | 1 |
| Aref, A; Ehsanpour, A; Ghorbani, A; Shahbazian, H | 1 |
| Gabriel, CL; Kastelein, JJ; Major, AS; Mendez-Fernandez, YV; Stroes, ES; Tak, PP; van Leuven, SI; Wade, NS; Wilhelm, AJ | 1 |
| Budde, K; Doueiri, S; Fabritius, K; Lehnert, M; Lorkowski, C; Mashreghi, MF; Matz, M; Neumayer, HH; Unterwalder, N; Weber, UA | 1 |
| Catar, R; Chaykovska, L; Dragun, D; Fuller, TF; Haller, M; Hoff, U; Kusch, A; Pützer, J; Troppmair, J | 1 |
| Klintmalm, GB; Ruiz, R | 1 |
| Broscheit, C; Egli, A; Humar, A; Kumar, D; O'Shea, D | 1 |
| Beckebaum, S; Cicinnati, VR; Kabar, I; Radtke, A | 1 |
| Budde, K; Fabritius, K; Lehnert, M; Lorkowski, C; Mashreghi, MF; Matz, M; Neumayer, HH; Weber, UA | 1 |
| Bossart, W; Etter, A; Fehr, T; Hässig, A; Müller, N; Roos, M; Schiesser, M; Wüthrich, RP | 1 |
| Foley, P; Kelly, JB; Strober, BE | 1 |
| Hamburger, AW; Lee, Y; Mitchell, BS; Nguyen, le XT; Sunwoo, JB; Urbani, L; Utz, PJ | 1 |
| Karam, S; Wali, RK | 1 |
| Aguiar, W; Campos, E; Cristelli, M; Felipe, C; Ferreira, A; Franco, M; Gerbase de Lima, M; Hannun, P; Medina-Pestana, J; Sandes-Freitas, T; Tedesco-Silva, H | 1 |
| Christopher-Stine, L; Paik, JJ | 1 |
| Amrouche, K; Jamin, C | 1 |
| Lacour, JP | 1 |
| Fukahori, H; Hamakawa, N; Hirose, J; Inami, M; Maeda, M; Morio, H; Morokata, T; Nakamura, K; Nakanishi, T; Noto, T; Oshima, S; Tsujimoto, S | 1 |
6 review(s) available for pyrroles and mycophenolic acid
| Article | Year |
|---|---|
Evaluation of the novel protein kinase C inhibitor sotrastaurin as immunosuppressive therapy after renal transplantation.
Topics: Calcineurin Inhibitors; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclosporine; Drug Evaluation; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Protein Kinase C; Protein Kinase Inhibitors; Pyrroles; Quinazolines; Sirolimus; Tacrolimus; Treatment Outcome | 2011 |
Renal-sparing regimens employing new agents.
Topics: Abatacept; Calcineurin Inhibitors; Cyclosporine; Everolimus; Graft Rejection; Humans; Immunoconjugates; Immunosuppressive Agents; Kidney; Kidney Transplantation; Mycophenolic Acid; Pyrroles; Quinazolines; Sirolimus; TOR Serine-Threonine Kinases | 2012 |
Calcineurin inhibitors in liver transplantation - still champions or threatened by serious competitors?
Topics: Abatacept; Calcineurin Inhibitors; Everolimus; Humans; Immunoconjugates; Immunosuppression Therapy; Liver Transplantation; Mycophenolic Acid; Precision Medicine; Pyrroles; Quinazolines; Renal Insufficiency; Risk Factors; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases | 2013 |
Current and future oral systemic therapies for psoriasis.
Topics: Acitretin; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Cyclosporine; Fumarates; Humans; Hydroxyurea; Immunosuppressive Agents; Isoxazoles; Keratolytic Agents; Leflunomide; Methotrexate; Mycophenolic Acid; Piperidines; Protein Kinase Inhibitors; Psoriasis; Pyrimidines; Pyrroles; Sulfasalazine; Thalidomide; Thioguanine | 2015 |
Current State of Immunosuppression: Past, Present, and Future.
Topics: Abatacept; Alemtuzumab; Animals; Antibodies, Monoclonal, Humanized; Azathioprine; Bone Marrow Transplantation; Calcineurin Inhibitors; Cyclosporine; Disease Models, Animal; Everolimus; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Lung Transplantation; Mycophenolic Acid; Piperidines; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Sirolimus; Tacrolimus | 2015 |
Influence of drug molecules on regulatory B cells.
Topics: Adrenal Cortex Hormones; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; B-Cell Activating Factor; B-Lymphocytes, Regulatory; CD40 Antigens; Cytokines; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Pyrroles; Quinazolines; Receptors, Antigen, B-Cell; Semaphorins; Sirolimus; Toll-Like Receptors; Tretinoin; Vitamin D; Vitamins | 2017 |
9 trial(s) available for pyrroles and mycophenolic acid
| Article | Year |
|---|---|
Effect of atorvastatin on postcardiac transplant increase in low-density lipoprotein cholesterol reduces development of intimal hyperplasia and progression of endothelial dysfunction.
Topics: Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Disease Progression; Endothelium, Vascular; Female; Heart Transplantation; Heptanoic Acids; Humans; Hyperplasia; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Postoperative Period; Pyrroles; Tunica Intima | 2003 |
Phase 1 dose-escalation study of CP-690 550 in stable renal allograft recipients: preliminary findings of safety, tolerability, effects on lymphocyte subsets and pharmacokinetics.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Graft Survival; Humans; Janus Kinase 3; Kidney Transplantation; Lymphocytes; Male; Middle Aged; Mycophenolic Acid; Piperidines; Pyrimidines; Pyrroles; Transplantation, Homologous | 2008 |
Calcineurin-inhibitor-free immunosuppression based on the JAK inhibitor CP-690,550: a pilot study in de novo kidney allograft recipients.
Topics: Adrenal Cortex Hormones; Adult; Aged; Biopsy; Calcineurin Inhibitors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Janus Kinases; Kaplan-Meier Estimate; Kidney; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Pilot Projects; Piperidines; Pyrimidines; Pyrroles; Tacrolimus; Transplantation, Homologous; Young Adult | 2009 |
Monitoring of the immunomodulatory effect of CP-690,550 by analysis of the JAK/STAT pathway in kidney transplant patients.
Topics: Animals; Blotting, Western; Cell Division; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Immunosuppressive Agents; Janus Kinase 3; Kidney Transplantation; Killer Cells, Natural; Monitoring, Physiologic; Mycophenolic Acid; Piperidines; Placebos; Prednisolone; Primates; Pyrimidines; Pyrroles; Rodentia; Safety; STAT5 Transcription Factor; T-Lymphocytes | 2009 |
Population pharmacokinetic analysis of mycophenolic acid coadministered with either tasocitinib (CP-690,550) or tacrolimus in adult renal allograft recipients.
Topics: Adult; Area Under Curve; Dose-Response Relationship, Drug; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Models, Biological; Mycophenolic Acid; Piperidines; Pyrimidines; Pyrroles; Tacrolimus | 2010 |
Biomarker assessment of the immunomodulator effect of atorvastatin in stable renal transplant recipients and hypercholesterolemic patients.
Topics: Adenosine Triphosphate; Adult; Aged; Atorvastatin; Biomarkers; Cell Proliferation; Culture Media, Conditioned; Cytokines; Female; Gene Expression Regulation; Heptanoic Acids; Humans; Hypercholesterolemia; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Pyrroles; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Tacrolimus; Transplantation | 2010 |
Pharmacokinetics of sotrastaurin combined with tacrolimus or mycophenolic acid in de novo kidney transplant recipients.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Longitudinal Studies; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Pyrroles; Quinazolines; Tacrolimus; Treatment Outcome; Young Adult | 2011 |
Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients.
Topics: Adult; Calcineurin Inhibitors; Female; Humans; Kidney Transplantation; Male; Mycophenolic Acid; Protein Kinase C; Pyrroles; Quinazolines; Tacrolimus | 2011 |
Alteration of panel-reactive antibodies following treatment with either atorvastatin or low-dose mycophenolate mofetil in sensitized hemodialysis patients.
Topics: Adult; Atorvastatin; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Kidney Failure, Chronic; Male; Mycophenolic Acid; Pyrroles; Renal Dialysis | 2011 |
13 other study(ies) available for pyrroles and mycophenolic acid
| Article | Year |
|---|---|
Interactions between HIV-1 and cytomegalovirus in human osteosarcoma cells carrying both viruses.
Topics: Antiviral Agents; Benzodiazepines; Cytomegalovirus; Drug Resistance, Microbial; Gene Products, env; Gene Products, tat; HIV-1; Humans; Mycophenolic Acid; Osteosarcoma; Proviruses; Pyrroles; Sequence Deletion; Superinfection; tat Gene Products, Human Immunodeficiency Virus; Tumor Cells, Cultured; Virus Replication | 1993 |
Combined use of the JAK3 inhibitor CP-690,550 with mycophenolate mofetil to prevent kidney allograft rejection in nonhuman primates.
Topics: Animals; Graft Survival; Janus Kinase 3; Kidney Transplantation; Macaca fascicularis; Models, Animal; Mycophenolic Acid; Piperidines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles | 2005 |
Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-/-) mice.
Topics: Animals; Atherosclerosis; Atorvastatin; CD4-Positive T-Lymphocytes; Cholesterol; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Genetic Predisposition to Disease; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunity, Cellular; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mice; Mice, Inbred C57BL; Mycophenolic Acid; Pyrroles | 2012 |
Effects of sotrastaurin, mycophenolic acid and everolimus on human B-lymphocyte function and activation.
Topics: Apoptosis; B-Lymphocytes; B7-1 Antigen; B7-2 Antigen; Cell Membrane; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Everolimus; Graft Rejection; Humans; Immunity, Humoral; Immunoglobulin G; Immunoglobulin M; Immunoglobulins; Immunosuppressive Agents; Interleukin-10; Leukocytes, Mononuclear; Mycophenolic Acid; Pyrroles; Quinazolines; Sirolimus; Transplantation, Homologous | 2012 |
Protein kinase C inhibition ameliorates posttransplantation preservation injury in rat renal transplants.
Topics: Adenosine; Allopurinol; Animals; Apoptosis; Biomarkers; Blotting, Western; Cell Proliferation; Cold Temperature; Creatinine; Cytokines; Cytoprotection; Delayed Graft Function; Glutathione; Immunohistochemistry; Inflammation Mediators; Insulin; Kidney; Kidney Transplantation; Male; Mycophenolic Acid; Organ Preservation; Organ Preservation Solutions; Protein Kinase C; Protein Kinase Inhibitors; Pyrroles; Quinazolines; Raffinose; Rats; Rats, Inbred Lew; Real-Time Polymerase Chain Reaction; Reperfusion Injury; Signal Transduction; Time Factors | 2012 |
Comparison of the effect of standard and novel immunosuppressive drugs on CMV-specific T-cell cytokine profiling.
Topics: Abatacept; Adult; Cytokines; Cytomegalovirus; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Humans; Immunoconjugates; Immunosuppressive Agents; In Vitro Techniques; Middle Aged; Mycophenolic Acid; Piperidines; Pyrimidines; Pyrroles; Sirolimus; T-Lymphocytes; Tacrolimus; Th1 Cells; Th2 Cells; Transcriptome | 2013 |
Combined standard and novel immunosuppressive substances affect B-lymphocyte function.
Topics: Apoptosis; B-Lymphocytes; B7-1 Antigen; Cell Proliferation; Cytokines; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Everolimus; Humans; Immunity, Humoral; Immunoglobulin G; Immunosuppression Therapy; Immunosuppressive Agents; Lymphocyte Activation; Mycophenolic Acid; Primary Cell Culture; Pyrroles; Quinazolines; Sirolimus | 2013 |
Association of BK viremia with human leukocyte antigen mismatches and acute rejection, but not with type of calcineurin inhibitor.
Topics: Adult; Aged; Allografts; Antibodies, Monoclonal; Azathioprine; Basiliximab; BK Virus; Cohort Studies; Cyclosporine; Female; Glomerular Filtration Rate; Graft Rejection; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Logistic Models; Male; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Polyomavirus Infections; Proteinuria; Pyrroles; Quinazolines; Recombinant Fusion Proteins; Tacrolimus; Tumor Virus Infections; Viremia | 2014 |
Regulation of ribosomal RNA synthesis in T cells: requirement for GTP and Ebp1.
Topics: Adaptor Proteins, Signal Transducing; Blotting, Western; Cell Proliferation; Cells, Cultured; DNA, Ribosomal; Gene Expression; Guanosine Triphosphate; HEK293 Cells; Humans; Jurkat Cells; Keratin-20; Lymphocyte Activation; Mutation; Mycophenolic Acid; Phosphorylation; Pol1 Transcription Initiation Complex Proteins; Proliferating Cell Nuclear Antigen; Promoter Regions, Genetic; Protein Binding; Protein Kinase C-delta; Pyrroles; Quinazolines; RNA Interference; RNA Polymerase I; RNA-Binding Proteins; RNA, Ribosomal; T-Lymphocytes | 2015 |
Efficacy and Safety of Elective Conversion From Sotrastaurin (STN) to Tacrolimus (TAC) or Mycophenolate (MPS) in Stable Kidney Transplant Recipients.
Topics: Adult; Antibodies; Cohort Studies; Drug Interactions; Drug Substitution; Everolimus; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Prospective Studies; Pyrroles; Quinazolines; Tacrolimus | 2016 |
A case of refractory dermatomyositis responsive to tofacitinib.
Topics: Azathioprine; Dermatomyositis; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Middle Aged; Mycophenolic Acid; Piperidines; Pyrimidines; Pyrroles; Retreatment; Treatment Failure; Treatment Outcome | 2017 |
[Current and upcoming treatments of adult atopic dermatitis].
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Glucocorticoids; Humans; Methotrexate; Mycophenolic Acid; Piperidines; Pyrimidines; Pyrroles; Thalidomide; Ustekinumab | 2017 |
Replacement of mycophenolate mofetil with a JAK inhibitor, AS2553627, in combination with low-dose tacrolimus, for renal allograft rejection in non-human primates.
Topics: Animals; Graft Rejection; Immunosuppressive Agents; Kidney Transplantation; Lymphocyte Activation; Macaca fascicularis; Male; Mycophenolic Acid; Piperidines; Pyrroles; Tacrolimus; Transplantation, Homologous | 2018 |